Affiliated Hospital of

Company snapshot

Affiliated Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Epilepsies, Partial. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: approved (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Affiliated Hospital of. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Affiliated Hospital of.

1. Jun 8, 2026 Clinical update

   Oral Zonisamide Therapy — Approved

View all clinical trial activity →

• What is Affiliated Hospital of?

  Affiliated Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Epilepsies, Partial. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USP

• Is Affiliated Hospital of publicly traded?

  Affiliated Hospital of appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Affiliated Hospital of develop or market?

  We link 3 drug profile(s) where Affiliated Hospital of is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/affiliated-hospital-of-nantong-university#company-drugs.

• What are the latest developments for Affiliated Hospital of?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Affiliated Hospital of focus on?

  Affiliated Hospital of focuses on Epilepsies, Partial based on our analysis of their pipeline programs and drug development activities.